A study in Sweden found a high incidence and prevalence of pediatric-onset multiple sclerosis (PoMS), particularly among females and in patients aged 16 or 17. The research, aiming to support healthcare planning and clinical trial implementation, highlighted the need for focused resources on this vulnerable group.
